Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
212,883,456
-
Total 13F shares
-
19,471,110
-
Share change
-
-1,390,139
-
Total reported value
-
$96,376,641
-
Put/Call ratio
-
50%
-
Price per share
-
$4.95
-
Number of holders
-
74
-
Value change
-
-$30,443,305
-
Number of buys
-
50
-
Number of sells
-
19
Institutional Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q2 2016
As of 30 Jun 2016,
OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,471,110 shares.
The largest 10 holders included
FMR LLC, JENNISON ASSOCIATES LLC, Versant Venture Management, LLC, SV Life Sciences Advisers, LLC, FEDERATED INVESTORS INC /PA/, Polaris Venture Management Co. V, L.L.C., WELLINGTON MANAGEMENT GROUP LLP, BlackRock Fund Advisors, VANGUARD GROUP INC, and PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C..
This page lists
74
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.